The Precision Peptide Company Inc. PNGAF

Company Overview

The Precision Peptide Company Inc. (commonly known as BPC or PPC) is a privately held biotechnology services company specializing in custom peptide synthesis and related peptide-based research and manufacturing services. The company operates within the biotechnology and life sciences research tools industries, providing products and services primarily to pharmaceutical companies, biotechnology firms, academic research institutions, and diagnostic developers. Its core offerings focus on the design, synthesis, purification, and modification of peptides used in drug discovery, preclinical research, clinical development, and diagnostic applications.

Founded in the mid‑1990s, the company was established to address growing demand for high-quality, custom-engineered peptides with reliable turnaround times and regulatory-grade manufacturing capabilities. Over time, BPC expanded from research-grade peptide synthesis into more advanced capabilities, including GMP-compliant manufacturing and complex peptide chemistries, positioning itself as a specialized provider for both early-stage research and regulated development programs. While often referenced as BPC, public sources inconsistently report the company’s formal legal naming, and data inconclusive based on available public sources regarding any historical name changes.